🔗 Visit the ClinicalTrials.gov page for NCT00664898
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy. | Curr Opin Immunol | 2013 | 1.16 |
| 2 | Antibody-based therapies in multiple myeloma. | Bone Marrow Res | 2011 | 0.98 |
| 3 | Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. | Immunotherapy | 2015 | 0.81 |
| 4 | Target Therapy in Hematological Malignances: New Monoclonal Antibodies. | Int Sch Res Notices | 2014 | 0.76 |